Adaptive Hybrid Surgery Analysis

Versión de software: 1.0
Asegúrese de que selecciona la versión de software correcta. Para ello, seleccione el logotipo de Brainlab, que está situado en la esquina inferior derecha de la aplicación correspondiente.

Tumor Analysis



Adaptive Hybrid Surgery Analysis analyzes the potential effect of each template plan on each tumor.

For each plan, the actual result for the tumor is displayed with the given value (in brackets). For tumors, the given values define the prescription for the minimum volume coverage and the objective for the conformity index.

  • Volume Coverage (%): Indicates how much of the tumor volume should be covered by the dose. The given value (in brackets) is the minimum volume coverage required for an acceptable plan.

  • Conformity Index (CI): Indicates how accurately the volume of dose distribution matches the size and shape of the target volume, while taking normal tissue considerations into account. The given value (in brackets) shows the maximum CI for an acceptable plan.

Visual Indicators

These visual indicators are used in the symbols.

  • Green: The prescription Volume Coverage (%) or objective Conformity Index (CI) is met.

  • Red: The prescription Volume Coverage (%) or objective Conformity Index (CI) is violated.

Symbol Description


(All green)

  • The prescription is met for Volume Coverage (%).
  • The objective is met for Conformity Index (CI).


(Outer green, inner red)

  • (Green) The prescription is met for Volume Coverage (%).

  • (Red) The objective is violated for Conformity Index (CI).



(Outer red, inner green)

  • (Red) The prescription is violated for Volume Coverage (%).

  • (Green) The objective is met for Conformity Index (CI).



(All red)

  • The prescription is violated for Volume Coverage (%).

  • The objective is violated for Conformity Index (CI).


(Grey)

It is not possible to calculate a viable dose plan for this data set. This may be because:

  • The tumor is too large.

  • Volume Coverage (%) and Conformity Index (CI) are ignored.

Article No. 60919-43EN

Fecha de publicación: 2019-03-29